Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, John D. Sheppard, MD, MMSc, FACS, discusses “exciting” treatments for neurotrophic keratitis.
Sheppard, of Virginia Eye Consultants, highlights therapies for neurotrophic keratitis as well as treatment modalities for severe cases, such as Oxervate (cenegermin-bkbj, Dompé), amniotic membranes and preventive measures in high-risk populations. Therapies in the pipeline include a hepatocyte growth factor from Claris Bio.
“There are several other companies looking at neurotrophic disease as well, which will come to the forefront